US judge recommends terminating US Xyrem antitrust litigation
MLex Summary: Following class settlements, a US judge recommended terminating multidistrict litigation in which Jazz, Hikma and other pharmaceutical companies were alleged to have executed an anticompetitive scheme to impair and delay...To view the full article, register now.
Already a subscriber? Click here to view full article